D-dimer levels decline after immunosuppressive treatment rather than anticoagulant treatment in severe autoimmune chronic spontaneous urticaria.

Chronic urticaria D-dimer coagulation cyclosporine disease activity treatment response

Journal

European annals of allergy and clinical immunology
ISSN: 1764-1489
Titre abrégé: Eur Ann Allergy Clin Immunol
Pays: Italy
ID NLM: 101466614

Informations de publication

Date de publication:
28 Oct 2022
Historique:
entrez: 28 10 2022
pubmed: 29 10 2022
medline: 29 10 2022
Statut: aheadofprint

Résumé

Chronic spontaneous urticaria (CSU) is a common dermatological condition presenting with wheals and/or angioedema for more than 6 weeks. The role of autoimmunity and inflammation in the pathogenesis of CSU have been studied, but the precise mechanism remains unknown. Association with coagulation cascade has been suggested based on the observations of increased coagulation indicators such as serum D-dimer levels. We report an omalizumab refractory case of severe CSU with high D-Dimer levels that declined only after disease remission with cyclosporine treatment but not with anticoagulation. Activation of coagulation cascade occurs secondary to the pro-inflammatory state in CSU patients and the correlation between D-dimer levels and disease activity may indicate the need for more studies to better understand the relationship of D-dimer levels and Omalizumab resistance. Clinicians should consider this relationship in CSU patients with significant D-dimer levels before considering treatment with anticoagulants.

Identifiants

pubmed: 36305339
doi: 10.23822/EurAnnACI.1764-1489.272
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Auteurs

D Baskurt (D)

School of Medicine, Koç University, Istanbul, Turkey.

E Sarac (E)

Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.

R Asero (R)

Allergology Clinic, Clinica San Carlo, Paderno Dugnano, Milan, Italy.

E Kocatürk (E)

Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.
Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.

Classifications MeSH